Blog
Why TSMC Is a Better AI Stock to Hold Right Now Than Broadcom
AI spending remains concentrated around advanced computing infrastructure, benefiting companies involved in chip design, manufacturing, packaging and memory. Yet, recent market actions suggest that
3 Top Breakout Stocks to Buy in June for Strong Upside Potential
With June now underway, investors may benefit from a proactive stock selection approach by identifying stocks trading within well-defined price ranges and showing breakout opportunities. In this
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
Cencora COR is trying to do more than move pharmaceuticals from point A to point B. The company is leaning into higher-value services that help manufacturers reach community sites of care, while
Affirm's Expanded CPP Investments Deal Supports $8B in Loan Volume
Affirm Holdings, Inc. AFRM has renewed and expanded its funding partnership with Canada Pension Plan Investment Board (CPP Investments). Under the new 24-month forward-flow agreement, CPP
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
Glaukos Corporation’s GKOS growth prospects are supported by the continued expansion of interventional glaucoma, growing clinical and commercial synergies between iDose TR and iStent infinite, and
Celanese Streamlines Engineered Materials Network Across Asia
Celanese Corporation CE is shifting production from its Engineered Materials compounding facility in Ulsan, South Korea, to its plants in Nanjing and Shenzhen, China, and Silvassa, India. The move
ICLR Earnings Reset: What the Accounting Probe Changed
ICON plc ICLR is moving through a credibility and earnings reset that is now as much about controls as it is about demand. The company has laid out the scope of its accounting findings, flagged
Block's Cash App Unveils NFC-Powered Tags for Faster Payments
Block’s XYZ Cash App, the popular peer-to-peer payment platform, is introducing a new way to pay with the launch of Cash App Tags. These NFC-enabled physical payment accessories allow customers to
Here's Why Investors Should Hold on to Teladoc Health Stock for Now
Teladoc Health, Inc. TDOC is a pioneer and global leader in the telemedicine industry. It has a broad international presence, serving clients, supporting medical operations and reaching members
AGEN Early Access Revenues Signal a New Path Ahead of Approval
Agenus AGEN is taking an uncommon route to validate demand for its lead immuno-oncology combination, botensilimab plus balstilimab (BOT+BAL), before a traditional launch. Instead of waiting for full
Is Agenus Stock a Hold Amid Valuation and Funding Risks?
Agenus AGEN sits at a classic biotech crossroads. On one side is BOT+BAL, a lead immuno-oncology program being tested in a late-stage setting where current checkpoint inhibitors have historically
AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC
Agenus AGEN centered its investment case on botensilimab plus balstilimab (BOT+BAL), a checkpoint combination being advanced in refractory microsatellite stable (MSS)/mismatch repair proficient
Why Now Is the Time to Buy Low-Priced Stocks
Investors are always trying to time the market. They want to get in at the lows and get out at the highs. While this simplistic goal sounds easy, it is almost impossible to achieve.Regardless of
Samsara Q1 Earnings & Revenues Beat Estimates, FY27 Outlook Raised
Samsara Inc. IOT reported better-than-expected first-quarter fiscal 2027 results, with both earnings and revenues surpassing the Zacks Consensus Estimate.Samsara’s first-quarter non-GAAP earnings of
CNI Hits New Propane Shipment Record, Reflecting Strong Export Demand
Canadian National Railway’s CNI latest propane shipment record highlights the company's ability to unlock additional capacity within its existing network through operational improvements rather than
SoFi's Rule of 40 Strength is Becoming Impossible for Investors to Ignore
SoFi Technologies SOFI is increasingly separating itself from traditional fintech peers, and one metric appears to explain why: the company’s sustained Rule of 40 performance.
The Rule of 40, which
Will BP's Exploration-Led Upstream Strategy Drive Long-Term Growth?
BP plc BP, the British oil and gas giant, is refocusing its attention on upstream growth to boost long-term shareholder value. The upstream growth strategy is primarily centred on replacing its
Here's How Cenovus Is Built to Weather Heavy Oil Price Volatility
Cenovus Energy Inc. CVE is a Canadian integrated energy company with operations spanning the upstream and downstream sectors. While Cenovus benefits from the low-cost and long reserve life of its
Here's How ExxonMobil's Advantaged Assets Drive Growth and Resilience
Exxon Mobil Corporation XOM, the U.S. oil and gas giant, has an integrated business model spanning upstream operations, refining and trading. XOM continues to strengthen its production outlook
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
Shares of Alvotech ALVO, a biotechnology company specializing in the development and manufacturing of biosimilar medicines, jumped 19% after the company announced the resubmission of biologics





